Aimovig 140 mg Solution for injection

Licence status
Authorised: 26/04/2019
Active substances
ERENUMAB
Dosage Form
Solution for injection in pre-filled syringe
Licence number
EU/1/18/1293/004-006
Licence holder
Novartis Pharma GmbH

Product documents

Licence information

ATC code
N02CX07 erenumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/04/2019